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Abstract
The aim of present study was to investigate the effects of kaempferol on cellular proliferation and cell cycle arrest and explore the mechanism
for these effects in human breast carcinoma MDA-MB-453 cells. Cells were treated with kaempferol at various concentrations (ranging from 1
to 200 µM) for 24 and 48 hrs. Kaempferol significantly inhibited cancer cell growth in cells exposed to 50 and 10 µM of kaempferol and incubated
for 24 and 48 hrs, respectively. Exposure to kaempferol resulted in cell cycle arrest at the G2/M phase. Of the G2/M-phase related proteins, kaempferol
down-regulated CDK1 and cyclin A and B in cells exposed to kaempferol. In addition, small DNA fragments at the sub-G0 phase were increased
by up to 23.12 and 31.90% at 10 and 50 µM incubated for 24 and 48 hrs, respectively. The kaempferol-induced apoptosis was associated with 
the up-regulation of p53. In addition, the phosphorylation of p53 at the Ser-15 residue was observed with kaempferol. Kaempferol inhibits cell 
proliferation by disrupting the cell cycle, which is strongly associated with the induction of arrest at G2/M phase and may induce apoptosis via
p53 phosphorylation in human breast carcinoma MDA-MB-453 cells.
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Among natural antioxidants, flavonoids are most abundant in 
our daily foods. The common structure of flavonoids is the flavan 
nucleus, which consists of 15 carbon atoms arranged in three 
rings (phenylchromanone structure, C6-C3-C6). Rings A and B 
are benzene rings and ring C is a heterocyclic pyran or pyrone. 
The flavonols kaempferol, myricetin, and quercetin are 
members of the flavonoid subclass and are found in many foods, 
including onions and tea (Miean & Mohamed, 2001; Ross & 
Kasum, 2002). Although the predominant component of these 
major flavonols in edible plants is quercetin, followed by 
myricetin and kaempferol (Miean & Mohamed, 2001), all three 
have antioxidant capacity (de Vries et al., 1998; Marfak et al., 
2003; Park et al., 2006). Nevertheless, kaempferol has been 
relatively unnoticed in comparison with quercetin or myricetin, 
and a few in vitro studies have assessed it. 
Recently, it was found that the flavonoids possessing antioxidant 
properties offer new, possible strategies for cancer chemotherapy. 
It has been reported that antioxidant enzyme activation by 
kaempferol may play an important role in apoptosis in human 
lung non-small carcinoma H460 cells (Leung et al., 2007). In 
addition, many studies have reported that kaempferol significantly 
inhibits cancer cell growth in vitro (Bestwick et al., 2007; 
Casagrande & Darbon, 2001; Knowles et al., 2000) and that this 
growth inhibition stimulates the signal transduction pathway 
leading to apoptosis. It has been shown to cause apoptosis in 
various cells, such as leukemia cells, lung cancer cells and 
glioblastoma (Chen et al., 2005; Leung et al., 2007; Nguyen et 
al., 2003a; Nguyen et al., 2003b), although the cellular 
mechanisms underlying the action of kaempferol- induced cell 
cycle arrest and apoptosis are still unclear. 
Therefore, the present study was performed to investigate the 
effects of kaempferol on cell proliferation and apoptosis and 
explored the mechanism for these effects in human breast 
carcinoma MDA-MB-453 cells.
Materials and Methods
The cell culture and kaempferol treatment
Human breast cancer MDA-MB-453 cells were purchased from 
the KCLB (Korean Cell Line Bank, Korea). Cells were routinely 
maintained in RPMI 1640 (Invitrogen [Molecular Probes], Gibco, 
Carlsbad, CA, USA), supplemented with 10% FBS and 
antibiotics (50 U/ml of penicillin and 50 μg/ml streptomycin, 
Gibco) at 37℃ in a humidified atmosphere containing 5% CO2. 
Cells were treated with kaempferol ranging from 1 to 200 μM 
and incubated for 24 and 48 hrs. Kaempferol was purchased from 
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Fig. 1. Effect of kaempferol on cell proliferation of MDA-MB-453 cells. Cells 
were exposed to either vehicle (0.1% DMSO in medium) or kaempferol (1-200 μM) 
and incubated for 24 and 48 hrs. All data are reported as the percentage change 
in comparison with the vehicle-only group, which were arbitrarily assigned 100% 
viability.  *P<0.05,  significantly  different  from  the  vehicle-only  group  (kaempferol 
concentration=“0”).
Sigma and dissolved in DMSO (final concentration 0.1% in 
medium).
Cell viability assay
Cell viability was determined using the
  MTT assay. At 24 and 
48 hrs point, the cells exposed to kaempferol were added to 
methyl thiazolyl tetrazolium (MTT). Four hours later, DMSO was 
added to each well to dissolve the resulting formazan crystals 
and then absorbance was recorded at 540 nm in a microplate 
reader
  (SpectraMax Plus; Molecular Devices). 
Cell cycle distribution
Cells were then harvested, washed with cold PBS,
  and 
processed for cell cycle analysis. Briefly, the cells were fixed 
in absolute ethanol. The fixed cells were centrifuged at 1,000 
rpm and washed with cold PBS twice. RNase A (20 µg/ml final 
concentration) and propidium iodide staining solution (50 µg/ml 
final concentration) were added to the cells and incubated for 
30 min at 37℃ in the dark. The cells were analyzed with a FACS 
Calibur instrument
  (BD Biosciences, San Jose, CA, USA) 
equipped with CellQuest 3.3 software. ModFit LT 3.1 trial cell 
cycle analysis software was used
  to determine the percentage 
of cells in the different phases
  of the cell cycle.
Immunoblotting assay
Cells were lysed in RIPA buffer (1% NP-40, 150 mM NaCl, 
0.05% DOC, 1% SDS, 50 mM Tris, pH 7.5) containing protease 
inhibitor for 1 hrs at 4℃. The supernatant was separated by 
centrifugation, and protein concentration was determined by 
Bradford protein assay kit II (Bio-Rad). Proteins (25 μg/well) 
denatured with sample buffer were separated by 10% SDS- 
polyacrylamide gel. Proteins were transferred onto nitrocellulose 
membranes (0.45 μm). The membranes were blocked with a 1% 
BSA solution for 3 hrs and washed twice with PBS containing 
0.2% Tween-20, and incubated with the primary antibody 
overnight at 4℃. Antibodies against p53, phosphorylated-p53 
(serine 6, 9, 15, 20, 37, 46, or 392) and β-actin were purchased 
from Cell Signaling (Cell Signaling Inc., MA, USA) and Santa
 
Cruz (Santa Cruz Biotechnology, Inc., CA, USA), respectively, 
and used to probe the separate membranes. The next day, the 
immunoreaction was continued with the secondary goat anti- 
rabbit horseradish-peroxidase–conjugated antibody after washing 
for 2 hrs at room temperature. The specific protein bands were 
detected by Opti-4CN Substrate kit (Bio-Rad Laboratories, CA, 
USA).
Statistical analysis
All data were expressed
  as percentage compared with vehicle- 
treated control
  cells, which were arbitrarily assigned 100%. Data 
were analyzed by one-way analysis of variance followed by 
Dunnett’s multiple comparison test (Sigma Stat, Jandel, San 
Rafael, CA, USA). For all comparisons, differences were considered 
statistically significant at P<0.05.
Results and Discussion
Recently, a great deal of attention has been focused on how 
flavonoids function in relation to their biological properties, 
especially in terms of their anticarcinogenic activity (Ren et al., 
2003; Galati & O’Brien PJ, 2004). In particular, kaempferol 
shows specific inhibitory activity for cancer cell growth (Nguyen 
et al., 2003a; Nguyen et al., 2003b; Yoshida et al., 2008; Zhang 
et al., 2008), but the mechanisms underlying the effects of 
kaempferol in the induction of cell cycle arrest and apoptosis 
in human breast cancer cells are still unknown. Although it has 
been reported that kaempferol has estrogen activity (Prouillet et 
al., 2004; Hung, 2004), estrogen-negative MDA-MB-453 cells 
were used because we wanted to investigate the estrogen- 
independent effects of kaempferol.
We first examined the antiproliferative effect of kaempferol 
on human breast cancer MDA-MB-453 cells at various concentrations 
(ranging from 1 to 200 μM) and exposure times (24 and 48 hrs) 
using the MTT assay (Fig. 1). The observed antiproliferative 
activity of kaempferol was consistent with reports that 
kaempferol inhibits cancer cell growth in various cells (Bestwick 
et al., 2007; Casagrande & Darbo, 2001; Knowles et al., 2000). 
A statistical difference was first seen at 50 and 10 µM for 24 
and 48 hrs, respectively, compared with controls.
To determine whether the anti-proliferative activity of kaempferol 
would lead to cell cycle arrest, we analyzed the cell cycle 
distribution of MDA-MB-453 cells treated with kaempferol using 
fluorescence-activated cell sorting (FACS) under the treatment 324 Kaempferol induced the apoptosis
Fig. 2. Effect of kaempferol on cell cycle distribution of MDA-MB-453 cells. 
Cells were exposed to either vehicle (0.1% DMSO in medium) or kaempferol at 50 
and 10 μM for 24 and 48 hrs, respectively. Values are expressed as percentage 
of  the  cell  population  in  the  G1,  S,  and  G1/M  phase  of  cell  cycle.  *P<0.05, 
significantly  different  from  the  vehicle-only  group  (kaempferol  concentration=“0”).
Fig. 3. Effect of kaempferol on protein expression related cell cycle arrest (A) 
and apoptosis (B) of human carcinoma MDA-MB-453 cells. Cells were exposed 
to  either  vehicle  (0.1%  DMSO  in  medium)  or  kaempferol  at  50  μM  for  24  hrs. 
conditions at which kaempferol had a significant result (50 and 
10 µM for 24 and 48 hrs, respectively). As shown in Fig. 2, 
a significant decrease in the number of G2-phase cells was seen 
with kaempferol treatment at concentrations of 50 and 10 μM 
for 24 and 48 hrs, respectively (8.75 and 9.84% of the cell 
population compared with control value 16.75%, p<0.05). These 
accumulations of the cell population in the G2/M phase were 
accompanied by a concomitant increase in the cell population 
in the S phase (28.12 and 30.90% of the cell population compared 
with control value 21.8%, p<0.05).
The cell cycle is tightly mediated through a complex network 
of positive and negative cell-cycle regulatory molecules such as 
cyclin-dependent kinases (CDKs) and CDK inhibitors (CKIs). 
Cyclin the down-regulation of CDK1 (Cdc2), as well as cyclin 
A and cyclin B, by kaempferol may be a main cause of the 
G/M phase arrest. CDK1 is a catalytic subunit of the M-phase 
promoting factor, which is activated at the G2/M transition and 
controls the onset of mitosis. Several investigators have shown 
that CDK1 in combination with cyclin A and cyclin B is critical 
in the G2/M phase transition (Jessus & Beach, 1992; Morla et 
al., 1989). In the present study, CDK1,  which is combined with 
cyclin A/B in the control of the G2/M phase, was markedly 
decreased by kaempferol (Fig. 3A). Thus, kaempferol inhibits 
the cell cycle at the G2/M phase via down-regulation of CDK1 
in human breast carcinoma MDA- MB-453 cells.
In addition, we observed a higher percentage of apoptosis in 
sub-G0 phase exposed to kaempferol. Compared to the vehicle- 
treated cells, the apoptotic cells exposed to kaempferol were 
observed 23.12 and 31.90 % at 10 and 50 μM for 24 and 48 
hrs, respectively. To scrutinize these results further, we investigated 
the apoptotic pathway in MDA-MB-453 cells exposed to 50 µM 
kaempferol for 24 hrs (Fig. 3).
Apoptosis is an important series of events leading to 
programmed cell death that is also essential for development and 
tissue homeostasis. Recently, the regulation of apoptosis has been 
proposed as a promising target for cancer chemotherapy (Fesik, 
2005; Sun et al., 2004; Zhang et al., 2005). The activation of 
p53 mediates coordinated antiproliferative effects, including 
effects on cell cycle and apoptosis (Guimaraes & Hainut, 2002). 
In this study, kaempferol increased the expression of p53, and 
then clearly induced the phosphorylation of p53 at serine 15, 
but not at serine 6, 9, 20, 37, 46, or 392 (data not shown). Several 
studies have shown that p53 phosphorylated at serine 15 is 
associated with apoptosis in cancer cells (Ito et al., 2004; Jiang 
et al., 2004; Mota et al., 1968). In addition, it has been reported 
that quercetin increased the levels of total p53 and p53 
phosphorylated at serine 15 in A549 cells (Kuo et al., 2004). 
Thus, kaempferol-induced apoptosis may be related to p53 
accumulation-mediated phosphorylation at serine 15 residues. 
Consequently, we suggest the existence of multiple pathways 
by which kaempferol results in G2/M-phase cell cycle arrest via 
downregulated CDK1 and apoptotic cell death via modulation 
of the p53 pathway. Therefore, the anticancer activity of 
kaempferol may be useful for developing anticancer medicine.
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